Mevalonate Kinase Deficiency: Disclosing the Role of Mevalonate Pathway Modulation in Inflammation

E-ISSN： 1873-4286|18|35|5746-5752

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.35, 2012-12, pp. : 5746-5752

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Basic and Clinical Observations of Mevalonate Depletion on the Mevalonate Signaling Pathway

Current Molecular Pharmacology, Vol. 10, Iss. 1, 2017-01 ,pp. : 6-12

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Cancer Therapy: Targeting the Mevalonate Pathway

Current Cancer Drug Targets, Vol. 6, Iss. 1, 2006-02 ,pp. : 15-37

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Mevalonate Pathway for Improved Anticancer Therapy

Current Cancer Drug Targets, Vol. 9, Iss. 5, 2009-08 ,pp. : 626-638

Bentham Science Publishers

Access to resources Recommend Favorite

The Mevalonate Pathway as a Therapeutic Target in the Ph-Negative Chronic Myeloproliferative Disorders

Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. : 247-256

Bentham Science Publishers

Access to resources Recommend Favorite

New Treatment Strategies for Multiple Myeloma by Targeting BCL-2 and the Mevalonate Pathway

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 327-340

Bentham Science Publishers

Access to resources Recommend Favorite